Imaging biomarkers of brain tumour margin and tumour invasion

Abstract

ABSTRACT. Invasion of tumour cells into the normal brain is one of the major reasons of treatment failure for gliomas. Although there is a good understanding of the molecular and cellular processes that occur during this invasion, it is not possible to detect the extent of the tumour with conventional imaging. However, there is an understanding that the degree of invasion differs with individual tumours, and yet they are all treated the same. Newer imaging techniques that probe the pathological changes within tumours may be suitable biomarkers for invasion. Imaging methods are now available that can detect subtle changes in white matter organisation (diffusion tensor imaging), tumour metabolism and cellular proliferation (using MR spectroscopy and positron emission tomography) occurring in regions of tumour that cannot be detected by conventional imaging. The role of such biomarkers of invasion should allow better delineation of tumour margins, which should improve treatment planning (especially surgery and radiotherapy) and provide information on the invasiveness of an individual tumour to help select the most appropriate therapy and help stratify patients for clinical trials.

Advanced Magnetic Resonance Imaging in Glioblastoma: A Review

“…Neurosurgeons will often utilize high-resolution MRI (0.5 -1.2mm slice thickness) for surgical planning and intraoperative guidance, as well as to make the determination of how aggressively to resect based on risk of toxicity to nearby eloquent regions. 4 Standard imaging also can identify other important characteristics of the mass in situ, including the amount of necrosis, compression of the surrounding normal tissue, and midline deviation.…”

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor

“…Previous studies based on the areas surrounding CER or NER regions of the tumor have focused on differentiating gliomas from metastatic lesions (8)(9)(10) or trying to delineate the exact tumor boundaries for surgical planning (11,12). Almost all extent-of-resection studies have focused on using the proportion of T he contrast material-enhancing region (CER) in gliomas, particularly in high-grade gliomas, is considered to represent the most aggressive component of the tumor.…”

Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings

“…Unfortunately, MRI can be misleading because of the diffuse or invasive character of these tumors. An intact blood-brain barrier (BBB) in patients with low-grade gliomas often prevents tumor enhancement [3]; the hyperintensity on T2WIs [4] can be caused by peritumoral changes such as edema and necrosis in the absence of tumor cells.…”